| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/22/2006 | US7094752 Peptide ligands of the urokinase receptor |
| 08/22/2006 | US7094751 High beta-conglycinin products and their use |
| 08/22/2006 | US7094750 Toxin for use in treating cancer; antitumor agents |
| 08/22/2006 | US7094749 Glial mitogenic factors, their preparation and use |
| 08/22/2006 | US7094609 Spatially addressable combinatorial chemical arrays in encoded optical disk format |
| 08/22/2006 | US7094603 Transgenic human cells expressing superantigens/antiproliferative agents for use as gene therapeutic tools in cancer treatment ; tissue engineering |
| 08/22/2006 | US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it |
| 08/22/2006 | US7094597 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 08/22/2006 | US7094590 Aggrecanase |
| 08/22/2006 | US7094587 16002 Molecules and uses therefor |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094575 For prophylaxis and therapy of phospholipase A2 (PLA2) related inflammatory conditions |
| 08/22/2006 | US7094572 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/22/2006 | US7094569 Polypeptide for use in the treatment and prevention of alopecia |
| 08/22/2006 | US7094566 IL-17 receptor like molecules and uses thereof |
| 08/22/2006 | US7094565 polynucleotides that code polypeptides having oxidoreductase or alcohol dehydrogenase activity, used for drug screening, diagnosis and prophylaxis of brain, gastrointerstinal or urogenital disorders |
| 08/22/2006 | US7094564 polynucleotides that code for lymphotoxin polypeptide receptors, used for screening antagonists and/or agonists to the receptors; genetic engineering |
| 08/22/2006 | US7094557 Antitumor agents; controlling cell proliferation |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094552 Diagnostic test kits |
| 08/22/2006 | US7094548 Polypeptide for use in purifying and separation of target peptides |
| 08/22/2006 | US7094547 Sperm specific proteins |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094545 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 08/22/2006 | US7094529 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor |
| 08/22/2006 | US7094428 Comprises silver and/or mercury and biopolymer such as collagen, thrombin, prothrombin, firbrin, fibrinogen, heparinase, and/or blood coaggulation factors, for uncontrolled bleeding |
| 08/22/2006 | US7094418 Crosslinkable macromers |
| 08/22/2006 | US7094415 And emollient and humectant, colostrum, lactoferrin and/or methyl sulfonyl methane; soothing sore muscles, expediting healing and repairing of skin and reducing visual appearance of cellulite |
| 08/22/2006 | US7094413 Combined therapy for treatment of HIV infection |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide |
| 08/22/2006 | US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
| 08/22/2006 | US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients |
| 08/22/2006 | US7094402 Polynucleotides (with nucleotide sequence operably linked to an expression control sequence) encoding the human IL-11 receptor and fragments |
| 08/22/2006 | US7094401 HCV core protein binding agents for treatment of hepatitis C virus infection |
| 08/22/2006 | US7094397 Methods and reagents for the treatment of multiple sclerosis |
| 08/22/2006 | US7094396 Method for making cytokine specific antibodies and uses thereof |
| 08/22/2006 | US7094201 System and method for genetically treating cardiac conduction disturbances |
| 08/22/2006 | CA2223049C Terminally sterilized osteogenic devices and preparation thereof |
| 08/22/2006 | CA2097878C Therapeutic agent for neutropenia |
| 08/22/2006 | CA2044468C Canine granulocyte macrophage colony stimulating factor |
| 08/17/2006 | WO2006086653A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/17/2006 | WO2006086643A1 Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
| 08/17/2006 | WO2006086544A2 Therapeutic combination of a vegf antagonist (vegf trap) and an anti-hypertensive agent |
| 08/17/2006 | WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | WO2006086157A1 Cell permeabilization and stabilization reagent and method of use |
| 08/17/2006 | WO2006085988A1 Methods for treating parkinson’s disease |
| 08/17/2006 | WO2006085974A2 Amphiphilic dendritic dipeptides & their self-assembly into helical pores |
| 08/17/2006 | WO2006085828A1 Methods for the detection of hepatocellular carcinoma |
| 08/17/2006 | WO2006085747A1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 08/17/2006 | WO2006085697A1 Combination therapy for cerebrovascular disease using adrenomedulin with mesenchymal stem cell |
| 08/17/2006 | WO2006085689A1 Anticancer agent to be combined with telomelysin |
| 08/17/2006 | WO2006085687A1 Composition containing dihomo-ϝ-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | WO2006085523A1 Composition inhibiting rise in blood glucose level |
| 08/17/2006 | WO2006085516A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | WO2006085417A1 Food for preventing life style-related diseases |
| 08/17/2006 | WO2006085100A1 Treatment of very low birthweight (vlbw) infants by increasing blood insulin levels |
| 08/17/2006 | WO2006085092A2 Methods and uses of antibodies in the purification of interferon |
| 08/17/2006 | WO2006085033A2 Pharmaceutical compositions for the treatment of prostate cancer |
| 08/17/2006 | WO2006084768A1 Pharmaceutical composition for the prevention and treatment of cancer |
| 08/17/2006 | WO2006084694A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition |
| 08/17/2006 | WO2006084573A1 Food products comprising hydrolysed milk solids with improved taste |
| 08/17/2006 | WO2006084560A1 Composition comprising peptide |
| 08/17/2006 | WO2006084463A1 Systemic treatment of infections with defensins |
| 08/17/2006 | WO2006084383A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | WO2006084353A1 Stabilized compositions for topical administration and methods of making same |
| 08/17/2006 | WO2006084351A1 Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates |
| 08/17/2006 | WO2006084337A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084333A1 Neuroprotective agents and methods of their use |
| 08/17/2006 | WO2006084327A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084319A1 Immunogenic molecules |
| 08/17/2006 | WO2006068720A3 Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| 08/17/2006 | WO2006066599A3 Mas related g protein coupled receptors as drug targets |
| 08/17/2006 | WO2006065861A3 Therapeutic formulations of keratinocyte growth factor |
| 08/17/2006 | WO2006064381A3 Protein formulation |
| 08/17/2006 | WO2006063132A3 Methods for improving the structure and function of arterioles |
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006059357A9 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 08/17/2006 | WO2006059164A3 Pyrrolopyridine-2-carboxylic acid amides |
| 08/17/2006 | WO2006059093A3 Fusion proteins |
| 08/17/2006 | WO2006055621A3 Histone deacetylase inhibitors and methods of use |
| 08/17/2006 | WO2006054278A8 Variants of pigment epithelium derived factor and uses thereof |
| 08/17/2006 | WO2006053184A3 Methods for treating or preventing a vascular disease |
| 08/17/2006 | WO2006052976A3 Improved dosing regimen of temozolomide for treating cancer based on the patient’s mgmt level |
| 08/17/2006 | WO2006050155A3 Cancer therapeutic compositions |
| 08/17/2006 | WO2006038007A3 Inhibitory analogues to block receptors for microbial pathogenic determinants |
| 08/17/2006 | WO2006036770A3 Combination therapy for the treatment of obesity |
| 08/17/2006 | WO2006031885A3 Kdr and vegf/kdr binding peptides |
| 08/17/2006 | WO2006023910A3 Method of treating, preventing, inhibiting or reducing damage to cardiac tissue |
| 08/17/2006 | WO2006007412B1 Peptide yy formulations having increased stability and resistance to microbial agents |
| 08/17/2006 | WO2006005707A3 Method for preventing and treating alzheimer´s disease |
| 08/17/2006 | WO2005117895A3 Compositions comprising meloxicam |
| 08/17/2006 | WO2005115363A3 Method for treating skeletal disorders resulting from fgfr malfunction |
| 08/17/2006 | WO2005112977A3 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 08/17/2006 | WO2005112924A3 Methods of treating cancer by inhibiting histone gene expression |
| 08/17/2006 | WO2005111072A3 Notch-based fusion proteins and uses thereof |
| 08/17/2006 | WO2005086674A3 Brhf1 as a cancer diagnostic marker |
| 08/17/2006 | WO2005084303A3 Interferon-beta polymer conjugates |
| 08/17/2006 | WO2005060722A3 Modulation of immune system function by modulation of polypeptide arginine methyltransferases |
| 08/17/2006 | WO2005056754A3 Compositions and methods to reduce mutagenesis |